{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T06:03:45Z","timestamp":1785132225154,"version":"3.55.0"},"reference-count":122,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jcardioanesthesia.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1053\/j.jvca.2018.04.048","type":"journal-article","created":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T14:15:26Z","timestamp":1524752126000},"page":"209-222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"title":["Stem Cell Therapies in Cardiovascular Disease"],"prefix":"10.1053","volume":"33","author":[{"given":"Maia","family":"Terashvili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeljko J.","family":"Bosnjak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2018.04.048_bib1","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart disease and stroke statistics-2017 update: A report from the American Heart Association","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2018.04.048_bib2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jacc.2014.10.031","article-title":"Remote ischemic conditioning","volume":"65","author":"Heusch","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2018.04.048_bib3","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0140-6736(12)60916-7","article-title":"Cardioprotection: Chances and challenges of its translation to the clinic","volume":"381","author":"Heusch","year":"2013","journal-title":"Lancet"},{"key":"10.1053\/j.jvca.2018.04.048_bib4","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1161\/CIRCULATIONAHA.111.032698","article-title":"New horizons in cardioprotection recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop","volume":"124","author":"Schwartz Longacre","year":"2011","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2018.04.048_bib5","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1161\/CIRCRESAHA.116.305348","article-title":"Molecular basis of cardioprotection signal transduction in ischemic pre-, post-, and remote conditioning","volume":"116","author":"Heusch","year":"2015","journal-title":"Circ Res"},{"key":"10.1053\/j.jvca.2018.04.048_bib6","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1413534","article-title":"Remote ischemic preconditioning and outcomes of cardiac surgery","volume":"373","author":"Hausenloy","year":"2015","journal-title":"New Engl J Med"},{"key":"10.1053\/j.jvca.2018.04.048_bib7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/JAHA.117.008077","article-title":"RIPHeart (Remote Ischemic Preconditioning for Heart Surgery] Study Collaborators): Myocardial dysfunction, postoperative neurocognitive dysfunction, and 1 year follow-up","volume":"7","author":"Meybohm","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1053\/j.jvca.2018.04.048_bib8","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0140-6736(07)61296-3","article-title":"Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: A randomised controlled trial","volume":"370","author":"Hausenloy","year":"2007","journal-title":"Lancet"},{"key":"10.1053\/j.jvca.2018.04.048_bib9","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0140-6736(13)61450-6","article-title":"Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: A single-centre randomised, double-blind, controlled trial","volume":"382","author":"Thielmann","year":"2013","journal-title":"Lancet"},{"key":"10.1053\/j.jvca.2018.04.048_bib10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1161\/CIRCRESAHA.117.312099","article-title":"Global overview of the Transnational Alliance for Regenerative Therapies in Cardiovascular Syndromes (TACTICS) recommendations: A comprehensive series of challenges and priorities of cardiovascular regenerative medicine","volume":"122","author":"Fernandez-Aviles","year":"2018","journal-title":"Circ Res"},{"key":"10.1053\/j.jvca.2018.04.048_bib11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00395-011-0168-x","article-title":"Stem cell-based therapies in ischemic heart diseases: A focus on aspects of microcirculation and inflammation","volume":"106","author":"Wu","year":"2011","journal-title":"Basic Res Cardiol"},{"key":"10.1053\/j.jvca.2018.04.048_bib12","doi-asserted-by":"crossref","first-page":"e1886","DOI":"10.1371\/journal.pone.0001886","article-title":"Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing","volume":"3","author":"Chen","year":"2008","journal-title":"PLoS One"},{"key":"10.1053\/j.jvca.2018.04.048_bib13","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1093\/eurheartj\/ehn456","article-title":"Bone marrow cells are a rich source of growth factors and cytokines: Implications for cell therapy trials after myocardial infarction","volume":"29","author":"Korf-Klingebiel","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2018.04.048_bib14","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.jtcvs.2006.06.028","article-title":"Bone marrow cells have a potent anti-ischemic effect against myocardial cell death in humans","volume":"132","author":"Kubal","year":"2006","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2018.04.048_bib15","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.yjmcc.2006.10.009","article-title":"In vitro and in vivo effects of bone marrow stem cells on cardiac structure and function","volume":"42","author":"Xu","year":"2007","journal-title":"J Mol Cell Cardiol"},{"key":"10.1053\/j.jvca.2018.04.048_bib16","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1161\/01.RES.0000225952.61196.39","article-title":"Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling","volume":"98","author":"Uemura","year":"2006","journal-title":"Circ Res"},{"key":"10.1053\/j.jvca.2018.04.048_bib17","doi-asserted-by":"crossref","first-page":"H886","DOI":"10.1152\/ajpheart.00142.2006","article-title":"Cytokines produced by bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes from ischemic injury","volume":"291","author":"Takahashi","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1053\/j.jvca.2018.04.048_bib18","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/01.RES.0000253487.02398.85","article-title":"Bone marrow Oct3\/4+ cells differentiate into cardiac myocytes via age-dependent paracrine mechanisms","volume":"100","author":"Pallante","year":"2007","journal-title":"Circ Res"},{"key":"10.1053\/j.jvca.2018.04.048_bib19","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1536\/jhj.42.759","article-title":"Coronary reperfusion following ischemia: Different expression of bcl-2 and bax proteins, and cardiomyocyte apoptosis","volume":"42","author":"Xie","year":"2001","journal-title":"Jpn Heart J"},{"key":"10.1053\/j.jvca.2018.04.048_bib20","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1253\/circj.67.334","article-title":"Protective effect of basic fibroblast growth factor against myocyte death and arrhythmias in acute myocardial infarction in rats","volume":"67","author":"Nishida","year":"2003","journal-title":"Circ J"},{"key":"10.1053\/j.jvca.2018.04.048_bib21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1089\/scd.2007.0175","article-title":"In vitro secreting profile of human mesenchymal stem cells","volume":"17","author":"Schinkothe","year":"2008","journal-title":"Stem Cells Dev"},{"key":"10.1053\/j.jvca.2018.04.048_bib22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jss.2008.03.019","article-title":"Adipose tissue-derived cells improve cardiac function following myocardial infarction","volume":"153","author":"Schenke-Layland","year":"2009","journal-title":"J Surg Res"},{"key":"10.1053\/j.jvca.2018.04.048_bib23","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/jcp.21701","article-title":"Secretome from mesenchymal stem cells induces angiogenesis via Cyr61","volume":"219","author":"Estrada","year":"2009","journal-title":"J Cell Physiol"},{"key":"10.1053\/j.jvca.2018.04.048_bib24","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0140-6736(03)14232-8","article-title":"Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy","volume":"362","author":"Askari","year":"2003","journal-title":"Lancet"},{"key":"10.1053\/j.jvca.2018.04.048_bib25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1634\/stemcells.22-3-405","article-title":"Functional expression of HGF and HGF receptor\/c-met in adult human mesenchymal stem cells suggests a role in cell mobilization, tissue repair, and wound healing","volume":"22","author":"Neuss","year":"2004","journal-title":"Stem Cells"},{"key":"10.1053\/j.jvca.2018.04.048_bib26","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.it.2005.08.002","article-title":"IGF-1, inflammation and stem cells: Interactions during muscle regeneration","volume":"26","author":"Mourkioti","year":"2005","journal-title":"Trends Immunol"},{"key":"10.1053\/j.jvca.2018.04.048_bib27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00395-016-0586-x","article-title":"From basic mechanisms to clinical applications in heart protection, new players in cardiovascular diseases and cardiac theranostics: Meeting report from the third international symposium on \u201cNew frontiers in cardiovascular research\u201d","volume":"111","author":"Cabrera-Fuentes","year":"2016","journal-title":"Basic Res Cardiol"},{"key":"10.1053\/j.jvca.2018.04.048_bib28","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00019501-200506000-00006","article-title":"Effects of mesenchymal stem cell transplantation on extracellular matrix after myocardial infarction in rats","volume":"16","author":"Xu","year":"2005","journal-title":"Coron Artery Dis"},{"key":"10.1053\/j.jvca.2018.04.048_bib29","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1634\/stemcells.2006-0347","article-title":"Effect of hypoxia on gene expression of bone marrow-derived mesenchymal stem cells and mononuclear cells","volume":"25","author":"Ohnishi","year":"2007","journal-title":"Stem Cells"},{"key":"10.1053\/j.jvca.2018.04.048_bib30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1532\/IJH97.07041","article-title":"Mesenchymal stem cells for the treatment of heart failure","volume":"86","author":"Ohnishi","year":"2007","journal-title":"Int J Hematol"},{"key":"10.1053\/j.jvca.2018.04.048_bib31","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.stem.2009.05.015","article-title":"Naive and primed pluripotent states","volume":"4","author":"Nichols","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1053\/j.jvca.2018.04.048_bib32","doi-asserted-by":"crossref","unstructured":"Kumari D. States of pluripotency: Na\u00efve and primed pluripotent stem cells. Available at: https:\/\/www.intechopen.com\/books\/pluripotent-stem-cells-from-the-bench-to-the-clinic\/states-of-pluripotency-na-ve-and-primed-pluripotent-stem-cells. Submitted: October 27th 2015, Reviewed: March 18th 2016 and Published: July 20th 2016; http:\/\/dx.doi.org\/10.5772\/63202.","DOI":"10.5772\/63202"},{"key":"10.1053\/j.jvca.2018.04.048_bib33","first-page":"2239","article-title":"Induced pluripotency: History, mechanisms, and applications. Genes","volume":"24","author":"Stadtfeld","year":"2010","journal-title":"Development"},{"key":"10.1053\/j.jvca.2018.04.048_bib34","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1242\/dev.030957","article-title":"Klf4 reverts developmentally programmed restriction of ground state pluripotency","volume":"136","author":"Guo","year":"2009","journal-title":"Development"},{"key":"10.1053\/j.jvca.2018.04.048_bib35","first-page":"19","article-title":"Direct reprogramming of adult cells: Avoiding the pluripotent state","volume":"7","author":"Kelaini","year":"2014","journal-title":"Stem Cells Cloning"},{"key":"10.1053\/j.jvca.2018.04.048_bib36","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.15252\/emmm.201504395","article-title":"Reprogramming and transdifferentiation for cardiovascular development and regenerative medicine: Where do we stand?","volume":"7","author":"Ebert","year":"2015","journal-title":"EMBO Molecular Med"},{"key":"10.1053\/j.jvca.2018.04.048_bib37","first-page":"21","article-title":"Human induced pluripotent stem cell-derived endothelial cells exhibit functional heterogeneity","volume":"5","author":"Rufaihah","year":"2013","journal-title":"Am J Translational Res"},{"key":"10.1053\/j.jvca.2018.04.048_bib38","doi-asserted-by":"crossref","first-page":"E30","DOI":"10.1161\/CIRCRESAHA.108.192237","article-title":"Functional cardiomyocytes derived from human induced pluripotent stem cells","volume":"104","author":"Zhang","year":"2009","journal-title":"Circ Res"},{"key":"10.1053\/j.jvca.2018.04.048_bib39","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1161\/CIRCRESAHA.112.269035","article-title":"MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes","volume":"110","author":"Jayawardena","year":"2012","journal-title":"Circ Res"},{"key":"10.1053\/j.jvca.2018.04.048_bib40","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1073\/pnas.1301019110","article-title":"Reprogramming of human fibroblasts toward a cardiac fate","volume":"110","author":"Nam","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.jvca.2018.04.048_bib41","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.yjmcc.2012.04.010","article-title":"A new approach to transcription factor screening for reprogramming of fibroblasts to cardiomyocyte-like cells","volume":"53","author":"Protze","year":"2012","journal-title":"J Mol Cell Cardiol"},{"key":"10.1053\/j.jvca.2018.04.048_bib42","doi-asserted-by":"crossref","first-page":"12667","DOI":"10.1073\/pnas.1304053110","article-title":"Induction of human cardiomyocyte-like cells from fibroblasts by defined factors","volume":"110","author":"Wada","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.jvca.2018.04.048_bib43","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.stemcr.2013.07.005","article-title":"Direct reprogramming of human fibroblasts toward a cardiomyocyte-like state","volume":"1","author":"Fu","year":"2013","journal-title":"Stem Cell Reports"},{"key":"10.1053\/j.jvca.2018.04.048_bib44","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1021\/mp2003576","article-title":"Transplanted induced pluripotent stem cells improve cardiac function and induce neovascularization in the infarcted hearts of db\/db mice","volume":"8","author":"Yan","year":"2011","journal-title":"Mol Pharm"},{"key":"10.1053\/j.jvca.2018.04.048_bib45","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1093\/eurheartj\/ehr166","article-title":"Induced pluripotent stem cell (iPSC)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction","volume":"32","author":"Mauritz","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2018.04.048_bib46","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1002\/stem.471","article-title":"Human induced pluripotent stem cells develop teratoma more efficiently and faster than human embryonic stem cells regardless the site of injection","volume":"28","author":"Gutierrez-Aranda","year":"2010","journal-title":"Stem Cells"},{"key":"10.1053\/j.jvca.2018.04.048_bib47","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/ALN.0b013e3182655e96","article-title":"Marked hyperglycemia attenuates anesthetic preconditioning in human-induced pluripotent stem cell-derived cardiomyocytes","volume":"117","author":"Canfield","year":"2012","journal-title":"Anesthesiology"},{"key":"10.1053\/j.jvca.2018.04.048_bib48","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/ALN.0b013e318167af2d","article-title":"Age-related attenuation of isoflurane preconditioning in human atrial cardiomyocytes - Roles for mitochondrial respiration and sarcolemmal adenosine triphosphate-sensitive potassium channel activity","volume":"108","author":"Mio","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1053\/j.jvca.2018.04.048_bib49","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1097\/ALN.0b013e3181eff6b7","article-title":"Isoflurane preconditioning elicits competent endogenous mechanisms of protection from oxidative stress in cardiomyocytes derived from human embryonic stem cells","volume":"113","author":"Sepac","year":"2010","journal-title":"Anesthesiology"},{"key":"10.1053\/j.jvca.2018.04.048_bib50","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1213\/ANE.0000000000001254","article-title":"High glucose attenuates anesthetic cardioprotection in stem-cell-derived cardiomyocytes: The role of reactive oxygen species and mitochondrial fission","volume":"122","author":"Canfield","year":"2016","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2018.04.048_bib51","doi-asserted-by":"crossref","first-page":"H44","DOI":"10.1152\/ajpheart.01056.2001","article-title":"Anesthetic preconditioning: Triggering role of reactive oxygen and nitrogen species in isolated hearts","volume":"283","author":"Novalija","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1053\/j.jvca.2018.04.048_bib52","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1093\/eurheartj\/ehp265","article-title":"Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy","volume":"30","author":"Schuleri","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2018.04.048_bib53","doi-asserted-by":"crossref","first-page":"685","DOI":"10.5966\/sctm.2012-0027","article-title":"Mesenchymal stem cell transplantation improves regional cardiac remodeling following ovine infarction","volume":"1","author":"Zhao","year":"2012","journal-title":"Stem Cells Transl Med"},{"key":"10.1053\/j.jvca.2018.04.048_bib54","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1161\/CIRCRESAHA.111.245969","article-title":"Autologous mesenchymal stem cells mobilize cKit(+) and CD133(+) bone marrow progenitor cells and improve regional function in hibernating myocardium","volume":"109","author":"Suzuki","year":"2011","journal-title":"Circ Res"},{"key":"10.1053\/j.jvca.2018.04.048_bib55","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1016\/j.jacc.2011.01.037","volume":"57","author":"Hu","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2018.04.048_bib56","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jtcvs.2006.08.077","article-title":"Intramyocardial delivery of CD133(+) bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: Safety and efficacy studies","volume":"133","author":"Stamm","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2018.04.048_bib57","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/CIRCRESAHA.116.308937","article-title":"Repeated administrations of cardiac progenitor cells are markedly more effective than a single administration: A new paradigm in cell therapy","volume":"119","author":"Tokita","year":"2016","journal-title":"Circ Res"},{"key":"10.1053\/j.jvca.2018.04.048_bib58","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00395-017-0606-5","article-title":"Repeated doses of cardiac mesenchymal cells are therapeutically superior to a single dose in mice with old myocardial infarction","volume":"112","author":"Guo","year":"2017","journal-title":"Basic Res Cardiol"},{"key":"10.1053\/j.jvca.2018.04.048_bib59","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1161\/CIRCRESAHA.114.303180","article-title":"Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting","volume":"114","author":"Karantalis","year":"2014","journal-title":"Circ Res"},{"key":"10.1053\/j.jvca.2018.04.048_bib60","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1161\/CIRCRESAHA.110.227512","article-title":"Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: A methods overview","volume":"111","author":"Mummery","year":"2012","journal-title":"Circ Res"},{"key":"10.1053\/j.jvca.2018.04.048_bib61","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nature11317","article-title":"Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts","volume":"489","author":"Shiba","year":"2012","journal-title":"Nature"},{"key":"10.1053\/j.jvca.2018.04.048_bib62","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4103\/0975-3583.83037","article-title":"Evaluation of the autologous bone marrow mononuclear therapy and functional restoration in the scarred myocardium by imaging analysis","volume":"2","author":"Gokhale","year":"2011","journal-title":"J Cardiovasc Dis Res"},{"key":"10.1053\/j.jvca.2018.04.048_bib63","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1161\/CIRCRESAHA.115.307676","article-title":"Jansen of Lorkeers SJ, et al. Cardiac stem cell treatment in myocardial infarction: A systematic review and meta-analysis of preclinical studies","volume":"118","author":"Zwetsloot","year":"2016","journal-title":"Circ Res"},{"key":"10.1053\/j.jvca.2018.04.048_bib64","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/CIRCRESAHA.108.176826","article-title":"Paracrine mechanisms in adult stem cell signaling and therapy","volume":"103","author":"Gnecchi","year":"2008","journal-title":"Circ Res"},{"key":"10.1053\/j.jvca.2018.04.048_bib65","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1755-1536-1-4","article-title":"Role of paracrine factors in stem and progenitor cell mediated cardiac repair and tissue fibrosis","volume":"1","author":"Burchfield","year":"2008","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1053\/j.jvca.2018.04.048_bib66","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1161\/CIRCRESAHA.117.310803","article-title":"Paracrine effects of the pluripotent stem cell-derived cardiac myocytes salvage the injured myocardium","volume":"121","author":"Tachibana","year":"2017","journal-title":"Circ Res"},{"key":"10.1053\/j.jvca.2018.04.048_bib67","doi-asserted-by":"crossref","first-page":"186","DOI":"10.5966\/sctm.2015-0101","article-title":"Concise review: Review and perspective of cell dosage and routes of administration from preclinical and clinical studies of stem cell therapy for heart disease","volume":"5","author":"Golpanian","year":"2016","journal-title":"Stem Cells Transl Med"},{"key":"10.1053\/j.jvca.2018.04.048_bib68","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0140-6736(05)67861-0","article-title":"Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: Double-blind, randomised controlled trial","volume":"367","author":"Janssens","year":"2006","journal-title":"Lancet"},{"key":"10.1053\/j.jvca.2018.04.048_bib69","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1093\/eurheartj\/ehp374","article-title":"Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial","volume":"30","author":"Meyer","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2018.04.048_bib70","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa055706","article-title":"Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction","volume":"355","author":"Lunde","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2018.04.048_bib71","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/eurheartj\/ehp073","volume":"30","author":"Tendera","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2018.04.048_bib72","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/CIRCHEARTFAILURE.108.843243","article-title":"Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction","volume":"3","author":"Assmus","year":"2010","journal-title":"Circ Heart Fail"},{"key":"10.1053\/j.jvca.2018.04.048_bib73","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1161\/CIRCULATIONAHA.107.734103","article-title":"The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: First randomized placebo-controlled study of myoblast transplantation","volume":"117","author":"Menasche","year":"2008","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2018.04.048_bib74","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1001\/jama.2012.418","article-title":"Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: The FOCUS-CCTRN trial","volume":"307","author":"Perin","year":"2012","journal-title":"JAMA"},{"key":"10.1053\/j.jvca.2018.04.048_bib75","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1001\/jama.2012.25321","article-title":"Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: The POSEIDON randomized trial","volume":"308","author":"Hare","year":"2012","journal-title":"JAMA"},{"key":"10.1053\/j.jvca.2018.04.048_bib76","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1161\/CIRCULATIONAHA.112.092627","article-title":"Administration of cardiac stem cells in patients with ischemic cardiomyopathy: The SCIPIO trial: Surgical aspects and interim analysis of myocardial function and viability by magnetic resonance","volume":"126","author":"Chugh","year":"2012","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2018.04.048_bib77","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jacc.2013.08.724","article-title":"Intracoronary cardiosphere-derived cells after myocardial infarction: Evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction)","volume":"63","author":"Malliaras","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2018.04.048_bib78","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00392-011-0327-y","article-title":"Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): Final 5-year results suggest long-term safety and efficacy","volume":"100","author":"Leistner","year":"2011","journal-title":"Clin Res Cardiol"},{"key":"10.1053\/j.jvca.2018.04.048_bib79","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jama.2013.282909","article-title":"Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: The TAC-HFT randomized trial","volume":"311","author":"Heldman","year":"2014","journal-title":"JAMA"},{"key":"10.1053\/j.jvca.2018.04.048_bib80","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1093\/eurheartj\/ehv136","article-title":"Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: A randomized placebo-controlled trial (MSC-HF trial)","volume":"36","author":"Mathiasen","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2018.04.048_bib81","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ijcard.2016.02.016","article-title":"Intramyocardial transplantation of mesenchymal stromal cells for chronic myocardial ischemia and impaired left ventricular function: Results of the MESAMI 1 pilot trial","volume":"209","author":"Guijarro","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1053\/j.jvca.2018.04.048_bib82","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1161\/CIRCULATIONAHA.112.001035","article-title":"Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: Effects on global left ventricular function","volume":"127","author":"Surder","year":"2013","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2018.04.048_bib83","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/eurheartj\/ehv493","article-title":"A randomized double-blind control study of early intra-coronary autologous bone marrow cell infusion in acute myocardial infarction: The REGENERATE-AMI clinical trial","volume":"37","author":"Choudry","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2018.04.048_bib84","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/CIRCRESAHA.115.308165","article-title":"PreSERVE-AMI: A randomized, double-blind, placebo-controlled clinical trial of intracoronary administration of autologous CD34+ cells in patients with left ventricular dysfunction post STEMI","volume":"120","author":"Quyyumi","year":"2017","journal-title":"Circ Res"},{"key":"10.1053\/j.jvca.2018.04.048_bib85","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/clc.22882","article-title":"Stem-cell therapy in ST-segment elevation myocardial infarction with reduced ejection fraction: A multicenter, double-blind randomized trial","volume":"41","author":"Nicolau","year":"2018","journal-title":"Clin Cardiol"},{"key":"10.1053\/j.jvca.2018.04.048_bib86","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/CIRCRESAHA.117.310712","volume":"121","author":"Bartolucci","year":"2017","journal-title":"Circ Res"},{"key":"10.1053\/j.jvca.2018.04.048_bib87","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1161\/CIRCRESAHA.117.311466","article-title":"TIME trial: Effect of timing of stem cell delivery following ST-elevation myocardial infarction on the recovery of global and regional left ventricular function: Final 2-year analysis","volume":"122","author":"Traverse","year":"2018","journal-title":"Circ Res"},{"key":"10.1053\/j.jvca.2018.04.048_bib88","unstructured":"Bouchard A. Stem cells in the treatment of heart failure. Available at: https:\/\/myheart.net\/articles\/stem-cells-in-the-treatment-of-heart-failure. Accessed June 14, 2017."},{"key":"10.1053\/j.jvca.2018.04.048_bib89","article-title":"Stem cell treatment for acute myocardial infarction","volume":"9","author":"Fisher","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.jvca.2018.04.048_bib90","article-title":"Stem cell therapy for chronic ischaemic heart disease and congestive heart failure","volume":"12","author":"Fisher","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.jvca.2018.04.048_bib91","series-title":"Stem cells: Scientific facts and fiction, ed 2","author":"Mummery","year":"2014"},{"key":"10.1053\/j.jvca.2018.04.048_bib92","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1365-2141.1999.01337.x","article-title":"A history of haemopoietic cell transplantation","volume":"105","author":"Thomas","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1053\/j.jvca.2018.04.048_bib93","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.bbmt.2012.11.001","article-title":"Umbilical cord blood transplantation supported by third-party donor cells: Rationale, results, and applications","volume":"19","author":"Van Besien","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1053\/j.jvca.2018.04.048_bib94","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.jtcvs.2005.07.023","article-title":"Repair of impaired myocardium by means of implantation of engineered autologous myoblast sheets","volume":"130","author":"Memon","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2018.04.048_bib95","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jtcvs.2006.01.024","article-title":"Grafted skeletal myoblast sheets attenuate myocardial remodeling in pacing-induced canine heart failure model","volume":"132","author":"Hata","year":"2006","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2018.04.048_bib96","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jtcvs.2006.01.052","article-title":"Myoblast-seeded biodegradable scaffolds to prevent post-myocardial infarction evolution toward heart failure","volume":"132","author":"Siepe","year":"2006","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2018.04.048_bib97","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1525-1594.2008.00595.x","article-title":"Hydrogel-based engineered skeletal muscle grafts normalize heart function early after myocardial infarction","volume":"32","author":"Giraud","year":"2008","journal-title":"Artif Organs"},{"key":"10.1053\/j.jvca.2018.04.048_bib98","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/cvr\/cvn149","article-title":"Porous tissue grafts sandwiched with multilayered mesenchymal stromal cell sheets induce tissue regeneration for cardiac repair","volume":"80","author":"Chen","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1053\/j.jvca.2018.04.048_bib99","doi-asserted-by":"crossref","first-page":"H2257","DOI":"10.1152\/ajpheart.00219.2008","article-title":"Enhanced recovery of mechanical function in the canine heart by seeding an extracellular matrix patch with mesenchymal stem cells committed to a cardiac lineage","volume":"295","author":"Potapova","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1053\/j.jvca.2018.04.048_bib100","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ejcts.2008.03.058","article-title":"Epicardial deposition of endothelial progenitor and mesenchymal stem cells in a coated muscle patch after myocardial infarction in a murine model","volume":"34","author":"Derval","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"issue":"2","key":"10.1053\/j.jvca.2018.04.048_bib101","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1109\/MEMB.2009.931792","article-title":"Cardiac tissue engineering using stem cells","volume":"28","author":"Bursac","year":"2009","journal-title":"IEEE Eng Med Biol Mag"},{"key":"10.1053\/j.jvca.2018.04.048_bib102","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.cardiores.2005.11.005","article-title":"Longer preservation of cardiac performance by sheet-shaped myoblast implantation in dilated cardiomyopathic hamsters","volume":"69","author":"Kondoh","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1053\/j.jvca.2018.04.048_bib103","doi-asserted-by":"crossref","first-page":"8155","DOI":"10.1073\/pnas.0602877103","article-title":"Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction","volume":"103","author":"Davis","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.jvca.2018.04.048_bib104","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cardiores.2006.03.023","article-title":"Heart muscle engineering: An update on cardiac muscle replacement therapy","volume":"71","author":"Zimmermann","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1053\/j.jvca.2018.04.048_bib105","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/jamacardio.2016.2750","article-title":"Potential strategies to address the major clinical barriers facing stem cell regenerative therapy for cardiovascular disease: A review","volume":"1","author":"Nguyen","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1053\/j.jvca.2018.04.048_bib106","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1161\/CIRCRESAHA.117.310599","article-title":"Intravenously delivered mesenchymal stem cells: Systemic anti-inflammatory effects improve left ventricular dysfunction in acute myocardial infarction and ischemic cardiomyopathy","volume":"120","author":"Luger","year":"2017","journal-title":"Circ Res"},{"key":"10.1053\/j.jvca.2018.04.048_bib107","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12933-017-0625-4","article-title":"Tissue-engineered smooth muscle cell and endothelial progenitor cell bi-level cell sheets prevent progression of cardiac dysfunction, microvascular dysfunction, and interstitial fibrosis in a rodent model of type 1 diabetes-induced cardiomyopathy","volume":"16","author":"Kawamura","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"10.1053\/j.jvca.2018.04.048_bib108","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/ten.a.2007.0092","article-title":"Effect of mechanical loading on three-dimensional cultures of embryonic stem cell-derived cardiomyocytes","volume":"14","author":"Shimko","year":"2008","journal-title":"Tissue Eng Part A"},{"key":"10.1053\/j.jvca.2018.04.048_bib109","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40814-017-0217-9","article-title":"Epicardial delivery of autologous atrial appendage micrografts during coronary artery bypass surgery-safety and feasibility study","volume":"3","author":"Nummi","year":"2017","journal-title":"Pilot Feasibility Stud"},{"key":"10.1053\/j.jvca.2018.04.048_bib110","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/nbt1327","article-title":"Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts","volume":"25","author":"Laflamme","year":"2007","journal-title":"Nat Biotechnol"},{"key":"10.1053\/j.jvca.2018.04.048_bib111","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1006\/jmcc.2001.1367","article-title":"Cardiomyocyte grafting for cardiac repair: Graft cell death and anti-death strategies","volume":"33","author":"Zhang","year":"2001","journal-title":"J Mol Cell Cardiol"},{"key":"10.1053\/j.jvca.2018.04.048_bib112","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1161\/01.RES.0000196562.73231.7d","article-title":"Engineering myocardial tissue","volume":"97","author":"Eschenhagen","year":"2005","journal-title":"Circ Res"},{"key":"10.1053\/j.jvca.2018.04.048_bib113","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1089\/ten.tea.2010.0659","article-title":"Cardiac cell sheet transplantation improves damaged heart function via superior cell survival in comparison with dissociated cell injection","volume":"17","author":"Sekine","year":"2011","journal-title":"Tissue Eng Part A"},{"key":"10.1053\/j.jvca.2018.04.048_bib114","first-page":"212","article-title":"Cardiac cell-derived exosomes: Changing face of regenerative biology","volume":"38","author":"Kishore","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2018.04.048_bib115","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10557-016-6698-6","article-title":"Exosomes and cardiovascular protection","volume":"31","author":"Davidson","year":"2017","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1053\/j.jvca.2018.04.048_bib116","doi-asserted-by":"crossref","first-page":"3409169","DOI":"10.1155\/2016\/3409169","article-title":"Harnessing the angiogenic potential of stem cell-derived exosomes for vascular regeneration","volume":"2016","author":"Alcayaga-Miranda","year":"2016","journal-title":"Stem Cells Int"},{"key":"10.1053\/j.jvca.2018.04.048_bib117","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","article-title":"Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells","volume":"9","author":"Valadi","year":"2007","journal-title":"Nat Cell Biol"},{"key":"10.1053\/j.jvca.2018.04.048_bib118","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/cvr\/cvu167","article-title":"Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction","volume":"103","author":"Barile","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1053\/j.jvca.2018.04.048_bib119","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1161\/CIRCRESAHA.116.304360","article-title":"Identification of therapeutic covariant microRNA clusters in hypoxia-treated cardiac progenitor cell exosomes using systems biology","volume":"116","author":"Gray","year":"2015","journal-title":"Circ Res"},{"key":"10.1053\/j.jvca.2018.04.048_bib120","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.yjmcc.2014.01.004","article-title":"Cardioprotection by remote ischemic preconditioning of the rat heart is mediated by extracellular vesicles","volume":"68","author":"Giricz","year":"2014","journal-title":"J Mol Cardiol"},{"key":"10.1053\/j.jvca.2018.04.048_bib121","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00395-014-0423-z","article-title":"MicroRNA-144 is a circulating effector of remote ischemic preconditioning","volume":"109","author":"Li","year":"2014","journal-title":"Basic Res Cardiol"},{"key":"10.1053\/j.jvca.2018.04.048_bib122","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.scr.2013.01.002","article-title":"Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K\/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia\/reperfusion injury","volume":"10","author":"Arslan","year":"2013","journal-title":"Stem Cell Res"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077018302817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077018302817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T19:25:30Z","timestamp":1549049130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053077018302817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":122,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1053077018302817"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2018.04.048","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stem Cell Therapies in Cardiovascular Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2018.04.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}